Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation

Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation Sharon Stancliff MD, Danielle Greene DrPH, and Howard A. Zucker MD, JD Affiliation Sharon Stancliff is with the AIDS Institute, New York State Department of Health, New York, NY. Danielle Greene is with the New York State Department of Health. Howard A. Zucker is the Commissioner of the New York State Department of Health.CopyRightCorrespondence should be sent to Danielle Greene, DrPH, Chief of Staff, New York State Department of Health, 90 Church Street, 15th Floor, New York, NY 10007 (e-mail: Danielle.greene@health.ny.gov). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link.CONTRIBUTORSS. Stancliff and D. Greene drafted and revised the editorial. H. A. Zucker reviewed versions and provided edits. All authors conceptualized the idea. https://doi.org/10.2105/AJPH.2019.305370 Accepted: August 24, 2019 Published Online: November 06, 2019